Skip to content

Methode Electronics MEI Medical — Depreciation

Similar metrics at other companies

Abbott logo
ABTMedical Devices — Depreciation
$100M+13.6%
Becton, Dickinson and Company logo
BDXMedical — D&A
$348.25M+14.6%
Medtronic logo
MDTMedical Surgical — Depreciation
$56M+5.7%
Mirion Technologies logo
MIRMedical Segment — D&A
$16.2M-1.2%
Baxter International logo
BAXMedical Products & Therapies — Depreciation
$51M+4.1%
Baxter International logo
BAXHealthcare Systems & Technologies — Depreciation
$24M-11.1%

Other financials

Income statement

See full
Revenue$298.1M+15.9%
Gross profit$72.2M+268%
Operating income$10.9M+146%
Net income-+100%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$139.6M+34.7%
Total debt$348.6M+1.4%
Total equity$677.5M-2.3%
Total assets$1.3B0.0%

Cash flow

See full
Operating cash flow$4.9M-86.2%
CapEx$5.8M-36.3%
Free cash flow$10.1M

Valuation

See full
Market cap$638.49M+99.2%
Enterprise value$847.49M+51.2%
P/S0.6×+0.3×

Profitability

See full
Gross margin19.8%+4.2pp
Operating margin0.9%+0.5pp
Net margin-3.5%-1.0pp
FCF margin4.3%-0.4pp

Returns & leverage

See full
Return on equity-5.3%-1.5pp
Debt / equity0.5×0.0×
Current ratio2.4×0.0×

Where this comes from

Reported directly by Methode Electronics in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Methode Electronics’s 10-K, filed June 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Methode Electronics's medical — depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Methode Electronics's medical — depreciation?
Methode Electronics (MEI) reported medical — depreciation of $0 in Q1 2026.
What is the long-term trend for Methode Electronics's medical — depreciation?
Over 5 years (2021 to 2026), Methode Electronics's medical — depreciation has grown at a -100.0% compound annual growth rate (CAGR), from $900K to $0.
What does medical — depreciation mean?
The non-cash expense representing the reduction in value of tangible fixed assets within the medical segment over time due to wear and tear. It is a key component in understanding the segment's asset utilization and replacement cycle.